A Universal Therapeutic Vaccine Leveraging Autologous Pre-Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells.
Wu F, Guo Z, Yang J, Ou Y, Xie X, Liao H, Guo C, Zhan Y, Wu H, Hu R, Xu Y, Tang X, Wang H, Ye L, He P, He C, Huang L, Luo S, Sun X, Yang Z.
Wu F, et al. Among authors: luo s.
Adv Mater. 2025 Jan 21:e2412430. doi: 10.1002/adma.202412430. Online ahead of print.
Adv Mater. 2025.
PMID: 39838750